L-DOPA therapy adjunct (University of Western Australia)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameL-DOPA therapy adjunct (University of Western Australia)
Drug Alias NameUWA-0101UWA-0122UWA-0121
ClassificationSmall molecules
Mechanisms of ActionSerotonin transporter inhibitorsDopamine transporter antagonists
TargetsDopamine transporterSerotonin transporter
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A